Specialty billing / Urology
Urology mixes office visits with a heavy schedule of in-office procedures, imaging, laboratory work and surgery. Cystoscopy alone spans a large code family where the base procedure and its variants are mutually exclusive, and many office procedures include supplies and imaging that practices either double-bill or forget entirely.
0
Years in revenue cycle
48h
Claim filing window
30d
Target days to payment
HIPAA
Compliant by design
Where it breaks
Diagnostic cystoscopy is included in nearly every therapeutic cystoscopic procedure. Reporting the diagnostic code alongside stent placement or biopsy produces automatic bundling denials on one of the specialty's highest-volume services.
Stents, catheters and injectable agents used during office procedures may be separately reportable or already included depending on the code and the payer. Practices frequently absorb the material cost or bill for items the code already covers.
A urodynamic study is a series of separately reportable components, each requiring its own documentation and interpretation. Practices bill a single line for the session and lose most of the study's value.
Prostate treatments, injectable and implantable therapies, and advanced imaging carry authorization requirements and specific clinical criteria. Scheduling before approval leaves the practice holding the cost of drugs and devices already used.
Frequently billed
Representative codes only. Actual coding follows current CPT/HCPCS guidance and payer policy.
Denials we prevent
FAQ
Generally no. The diagnostic cystourethroscopy code is designated a separate procedure and is included in therapeutic cystoscopic services performed at the same session. Report only the therapeutic code that describes the work performed. Billing both is one of the most common and most easily avoided bundling denials in urology.
Report each component performed as its own code, with documentation and an interpretation for each. A complete study may include uroflowmetry, cystometrogram, pressure flow study and electromyography. Billing a single line for the session under-reports the work substantially, but each component billed must be individually supported in the record.
It depends on the code and the payer. Some procedure codes include the device or agent in their valuation, and separate billing is denied. Others permit separate reporting of the supply, particularly high-cost implants and injectables. Checking the specific pairing before purchasing inventory avoids absorbing costs that were never recoverable.
Most often the diagnosis and the imaging guidance line. The indication should document the elevated PSA value, abnormal exam findings or prior results that prompted biopsy. Guidance is separately reportable only when not included in the biopsy code. Pathology billing must also be coordinated so specimen counts match the procedure note.
We verify requirements before scheduling and submit with the clinical criteria the specific policy names, including prior treatment trials where required. For therapies where the practice buys the drug or device in advance, we confirm approval in writing before the order is placed, so cost is never committed against an unapproved case.
Other specialties
Next step
Send us your specialty, claim volume and current billing setup. We will come back with a proposal you can act on.
